Director · Organogenesis Holdings Inc. · Class A Common Stock
Side
BUY
Value
$13K
Shares
5,000
Price
$2.68
Executed
Mar 9, 2026
Disclosed
Mar 11, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 9 executedMar 11, 2026 disclosed
ORGO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Leibowitz Arthur S filed this Form 4 reporting a open-market purchase of ORGO on Mar 9, 2026. It became public on Mar 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Leibowitz Arthur Scik:0001467329
Issuer
Organogenesis Holdings Inc.cik:0001661181
Revision history · 0
No field has changed since this record was first ingested.
